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reagents by chromatography and then the O-acetyl groups were removed from the sugar using a catalytic amount of a freshly prepared 1M sodium methoxide solution in methanol. Products 1 and 2 from this type of reaction were obtained after reverse phase column chromatography in good yield (Scheme 2).
The -thioglycosidic linkage in the two GlcNAc derivatives leading to 1 and 2 was deliberately prepared to obtain appropriate material for the specificity controls with MGL, because the -anomer of GalNAc had best reactivity with MGL in solid-phase testing of monosaccharide derivatives.
8b, c In the case of WGA, -linked GlcNAc in bivalent scaffolds binders was superior to the -anomer, and four such molecules gained access to all eight binding sites of WGA. 17 Interestingly, only a slight difference in K d -values between O-and Sglycosidic linkages had been found when performing titration calorimetry on WGA and tetravalent glycocyclopeptides (0.307 ± 0.003 µM for the O-glycosidic compound vs 0.54 ± 0.02 µM for the thioether). 18 No such data are available for MGL. In order to predict the reactivity level of the bivalent compounds for WGA we next performed molecular modeling and calculated the distance profiles of these bivalent compounds. In each case, the anomeric center was the reference point.
Molecular modeling of GlcNAc-presenting scaffolds
Using the Maestro interface (www.schrodinger.com), conformers were first built in an iterative manner, implementing the distance constraint from the reference point to its nearest aromatic C atom (bonded to an O atom) at 10.7 Å, then minimalisations were carried out in Macromodel (OPLSAA force field, gas phase). 3d Under these conditions, the two anomeric centers are separated by about 21 -22 Å (Fig. 1 , top part). Owing to conformational flexibility this distance can be shortened. It is likely that the two compounds 1 and 2 can thus 8 present their sugar moieties in a way that is able to bridge adjacent binding sites in WGA.
They are about 14 Å apart, 17 nourishing the assumption of strong inhibitory capacity.
Assaying inhibitory potency of the bivalent glycoclusters with GlcNAc on WGA
This hypothesis was tested in an assay, in which WGA interacts with the core of the complextype N-glycans of asialofetuin. The glycoprotein was adsorbed to the surface of microtiter plate wells, presenting its three bi-and triantennary N-glycans. Extent of binding of the labeled lectin is visualized by colorimetric detection so that any reduction in signal intensity by compound-dependent blocking of lectin binding was readily detected. As shown in Table   1 , both compounds are active as inhibitors, with about a twofold difference. Bivalency led to a large increase of inhibitory potency when compared to free GlcNAc, although the triazole as constituent of the linker is known to be much less favorable than a carbamate in the case of WGA. [17] [18] [19] Examined for other classes of lectins, e.g. galectins, such a difference between linkers is not a general phenomenon. 6e, 20 Extrapolation of inhibitory activity from the solidphase assay to cell binding was shown to be possible. WGA association to cell surfaces was susceptible to the presence of GlcNAc ( Fig. 2A) . As in the solid-phase system, both bivalent compounds were active, with the considerable enhancement relative to the free sugar ( Fig.   2A , B). To exclude a carbohydrate-independent effect by the core/linker parts an exchange of the sugar headgroup was performed, by incorporation of GalNAc in -thioglycosidic linkage.
The synthetic procedure now started with the respective -GalNAc derivative (Scheme 1),
with following processing performed as described above (Scheme 2) to produce compounds 3 and 4 from 12. These two pairs, i.e. 1/2 and 3/4, are thus sensors for carbohydrateindependent binding, an essential control for synthetic products. In order to characterize responses to a valency increase, to changes in anomeric linkage and the switch to an Oglycosidic bond we completed preparation of the panel of probes shown in Chart 1.
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Synthesis and molecular modeling of the glycoclusters with GalNAc
The -and -anomer derivatives of the thioglycoside 13 and 15 were prepared as described in Scheme 1 for GlcNAc (11). The -O-glycoside-containing azide 18 was obtained from the peracetylated 16 by glycosidation promoted by microwave irradiation with dichloroethane (to give 17) and then heating with reagents as given in Scheme 1 (bottom). These azide precursors 13, 15 and 18, together with the four alkyne reactants 19-22 (21 and 22 prepared as described 21 ), generated the compounds 5 and 6 (Scheme 2) and 7-9 (Scheme 3). Molecular modeling was performed as above to assess the distance profiles for sugar headgroups in the tri-and tetravalent products 5 and 6. The triangular presentation of 5 is characterized by a distance of about 21 Å (Fig. 1, bottom part) . Put in a rectangular conformation, distances of 14 Å and 27 Å were apparent for tetravalent 6 (Fig. 1, bottom Assaying the GalNAc-containing compounds 3 and 4 in concentrations up to 1 mM in the inhibition assays yielded no significant reduction of extent of signal development, thus no evidence for any carbohydrate-independent binding. As consequence, the panel could further be examined, first by assaying DBA.
Assaying inhibitory potency of the glycoclusters with GalNAc on DBA
Using a matrix with neoglycoprotein (-GalNAc as ligand presented by bovine serum albumin), DBA binding was found to be saturable and carbohydrate dependent. The binding of DBA to the sugar part of the neoglycoprotein was effectively reduced with the two GalNAc-containing compounds 3 and 4, but not by compounds 1 and 2 (Table 1) . This reactivity prompted us to proceed to determine activity levels of the other compounds with triand tetravalency (5, 6), the -linked thioglycoside (7) and the pair of bivalent -linked Oglycosides (8, 9). The outcome of the measurements was in line with the known preference to the -anomer, and rather small enhancements were recorded for the tri-and tetravalent compounds (Table 1) . Because the distance between the lectin's binding sites are outside of the range of distances in the synthetic clusters, with 55 Å and 68 Å for the two types of sides in the DBA tetramer, 22 no intramolecular bridging (chelate effect) as in WGA is possible.
This limits the inhibitory capacity, nonetheless documenting bioactivity of the sugar. As intended, these binding data set the stage for testing the glycoclusters against MGL.
Assaying inhibitory potency of glycoclusters on MGL in the solid-phase assay
Binding of the human C-type lectin to the matrix in both forms, i.e. as CRD and as the CRD + stalk, was saturable and completely dependent on the presence of Ca 2+ . When Ca 2+ was removed from the lectin by treatment with EDTA, abolishing the involvement of the cation in GalNAc binding by coordination bonds to the 3-and 4-OH groups, 8, 23 no significant signal in the assay was obtained. The same holds true if the 4-OH group is in the equatorial position as is the case for the GlcNAc derivatives; these products are not suited for coordination bonding.
Altering parameters in the five bivalent compounds, which present GalNAc, disclosed a preference for the -anomer (Table 1) . The reactivity was increased considerably for the MGL version containing the neck region. This was apparent for the -anomers at all degrees 11 of valency (Table 1) . The tetravalent compound reached the highest level of inhibitory potency in the solid-phase assay. Like in related C-type lectins and lectin-like proteins, 24 the -helical coiled-coil stalk acts as a mediator for trimerization, 8d and the effect of the tetravalent 6 on the CRD indicates the possibility of a glycocluster-induced aggregation contributing to the measured potency. Some flexibility between CRD and the -helical region will allow to adapt to a high-affinity interaction with clustered arrangements of -GalNAc residues. Physiologically, this will be the case for the T n -antigen and its sialylated version.
Assaying inhibitory potency of glycoclusters on MGL in cell assays
For the cell assays, a test system with large expression of the T n -antigen and its sialylated version would be ideal. The Lec8 mutant of the CHO system affords such a desired surface platform, because impairment in Gal transport into the Golgi attests mucin-type Oglycosylation at the stage of the sialyl T n -antigen. 25 This system was thus used, and dependence of MGL binding on the concentration for the CRD (Fig. 3A) and the (CRD + stalk) construct (Fig. 4A ), as well as the effect of free sugar (Fig. 3B, 4B ) corresponded to the results seen in the solid-phase assay. Increased efficiency for blocking (CRD + stalk) was apparent for the bi-and trivalent compounds 4 and 5 (Fig. 3C, Fig. 4C ) and especially for the tetravalent 6. Panels D in Fig. 3 and Fig. 4 underscore the strong response to presence of 6.
Glycocluster 6, along with the trivalent compound 5, also proved reactive with the two human galectins. In both cases, inhibition in the solid-phase assay reached an extent of about [25] [26] [27] [28] [29] [30] % of the signal at concentrations of 1.25-2.5 mM, that is at least about 1000fold less than that measured for MGL. Cross-reactivity of these compounds to both galectins will thus be minimal, fully in line with previous observations on lysine-/lysyllysine-based glycoclusters with Gal as headgroup, reactive with the C-type lectin of hepatocytes, and galectins-1 and -3.
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Conclusions
Our aim was to answer the question on favorable properties to turn synthetic glycoclusters into potent inhibitors of human MGL. Keeping linker structure and length constant, we varied the anomeric position, the atom in the anomeric centre and valency. The bioactivity of the compounds, together with a specificity control using a non-cognate headgroup, was first ascertained with two plant lectins. For the human lectin in solution, carbohydrate conjugation in the -anomeric position as the thioglycoside gave the best results for bivalent compounds.
Increase in valency enhanced inhibitory activity. The tetravalent compound 6 was highly potent, blocking binding to a matrix and to cells at nM concentration. Because association of a respective conjugate with an influenza virus led to a marked increase in fluorescence emission at 460 nm from this scaffold, already detectable by visual inspection under UV illumination, 21b a corresponding application may detect MGL shedding and resulting presence in serum. Cross-reactivity to mucin-binding galectins is already at a low level. If required, it could even be further diminished by using sialyl T n as a headgroup, a disaccharide which is unreactive with galectins. 13 However, the lectin of hepatocytes could recognize glycoclusters presenting T n and sialyl T n epitopes. Despite its original name "asialoglycoprotein receptor", this mammalian C-type lectin on the hepatic parenchymal cells binds N-glycans with 2,6-sialylated LacdiNAc along with unsubstituted -GalNAc termini (but not the 4'-sulfated LacdiNAc), with interspecies variations in relative affinity, and involvement of this lectin in mucin clearance from serum in mice suggests a respective reactivity confirmed for the rat receptor by glycan array data. 27 Of further note when considering extrapolations of data for MGL of different species, mice express MGL proteins with distinct carbohydrate specificities and expression profiles from two different genes.
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Experimental section
General experimental
Unless otherwise noted, all commercially available compounds were used as provided without further purification. Petroleum ether 40-60 °C was used for column chromatography and thin layer chromatography (TLC). NMR spectra were recorded (25 °C) 
2-Azidoethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-1-thio-α-D-glucopyranoside 11
Thiol 10 (3.12 g, 8.59 mmol) was dissolved in acetone-H 2 O (2:1, 36 mL) mixture and potassium carbonate (1.4 g, 10.1 mmol) and 1,2 dibromoethane (6 ml, 69.3 mmol) was added to this solution. This mixture was stirred at room temperature for 3 h after which point it was diluted with dichloromethane. The layers were separated, the aqueous layer then re-extracted with a further portion of dichloromethane. The combined organic layers were dried over The reaction was heated to 80 °C and stirred overnight at this temperature. It was then allowed to cool, after which it was diluted with dichloromethane and washed a number of times with H 2 O, to remove the DMF. The organic layer was dried over Na 2 SO 4 , and the solvent was removed under reduced pressure. Chromatography (EtOAc-petroleum ether, 1:3-1:1 gradient elution) led to the title compound (2.05 g, 88 %) as a white solid. 
2-Azidoethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-1-thio-α-D-galactopyranoside 13
Thiol 12 (2.50 g, 6.88 mmol) was treated as described for 10 and gave the title compound ( 
2-Chloroethyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-galactopyranoside 17
Compound 16 (2.0 g, 5.14 mmol) was dissolved in 1,2-dichloroethane (10 ml) in a microwave vial equipped with a stir bar. H 2 SO 4 -silica (37 mg) and 2-chloroethanol (0.43 ml, 6.41 mmol) were added to this mixture. It was then heated, stirred under microwave conditions at 110 °C for 15 min then filtered through Celite, followed by washing with dichloromethane. The filtrate washed with satd NaHCO 3 , brine, dried and the solvent was removed under reduced pressure. Column chromatography (EtOAc-petroleum ether, 1:3-1:1-2:1-1:0) gave the title 3266, 1642, 1596, 1553, 1373, 1286, 1180, 1153, 1119, 1078, 1037, 1023, 864, 759; R f : 0.64 3272, 1637, 1598, 1554, 1494, 1375, 1278, 1264, 1181, 1152, 1117, 1047, 1032, 1005, 891, 786, 759; R f : 0.70 (1:1 MeCN-H 2 O, reverse phase silica gel); α -5.5 (c 0.48, DMSO).
Lectin purification and quality controls Cloning of cDNA for the two MGL constructs and their recombinant production, further processing of inclusion bodies, protein solubilization, dialysis and affinity chromatography followed established protocols. 8f Purity was controlled by one-and two-dimensional gel electrophoresis. WGA was similarly purified by affinity chromatography as crucial step using fetuin as ligand immobilized to the resin after its activation with divinyl sulfone. 29 Biotinylation was performed under activitypreserving conditions with the N-hydroxysuccinimide ester derivative (Sigma, Munich, Germany). 30 Biotinylated DBA was purchased from Enzo Life Sciences, (Lörrach, Germany).
Inhibition assays
The surface of microtiter plate wells was coated with asialofetuin (for WGA and galectins) or an albumin-based neoglycoprotein presenting -GalNAc moieties as p-isothiocyanatophenyl derivative (for DBA and MGL) 31 using 0.5 µg/per well in 50 µl phosphate-buffered saline overnight at 4 °C. Residual surface area capable to adsorb protein was saturated using 100 µl buffer containing 1 % (w/v) carbohydrate-free bovine serum albumin for 1 h at 37 °C. The assay was then carried out by a series of incubation steps comprising use of the lectin without/with test substances, a streptavidin-peroxidase conjugate (0.5 µg/ml; Sigma) and reagents for signal development (1 µg/ml o-phenylenediamine, 1 µl/ml hydrogen peroxide), separated by thorough washing steps. Sigma) as indicator as described. 6e, 32 Measurements with the same lectin were routinely run with aliquots of the cell suspensions of the same passage, at least in duplicates, with at least four independent series. Controls included omission of the incubation step with the labeled lectin to determine lectin-independent background staining (0 %-value).
Fig. 1
Space filling models of 3-6 (left) and the estimated distances between anomeric carbon of the GalNAc residues in extended conformations of glycoclusters 3-6 (right) are specifically labelled. In compound 6, the distance along the diagonal between the anomeric carbons is ~30 Å (not shown). To obtain these confomatins, models were built using Maestro and energy minimisations were carried out using Macromodel (www.schrodinger.com). In generating the extended conformations shown, the distances between the anomeric carbon and nearest aromatic carbon (bonded to O) were constrained at 10.7 Å during the modeling run to reach the low-energy conformer in each case, and all anomeric carbons are assumed to be coplanar. concentrations of GlcNAc (0 mM, 2 mM, 10 mM, 100 mM). The numbers (from bottom to top) refer to the 100 %-value (0 mM GlcNAc), presence of 2 mM GlcNAc, 10 mM GlcNAc, 100 mM GlcNac and the background value. B: inhibition by 10 µM of compounds 2 and 1, numbers given (from bottom to top) referring to the 100 %-value, effects of 2, effect of 1 and the background value.
Fig. 3
Fluorescent cell (CHO Lec8 mutant) surface staining by the labeled C-type CRD (for further details, please see legend to Fig. 2) . A: staining parameters with increasing lectin concentrations (from top to bottom) in the listing of numbers of 1 µg/ml, 2 µg/ml and 5 µg/ml. B: staining parameters at a lectin concentration of 10 µg/ml in the absence of inhibitor (100 %-value) and in the presence of 10 mM GalNAc and 50 mM GalNAc (from bottom to top). C: staining parameters at a lectin concentration of 10 µg/ml in the absence of inhibitor (100 %-value) and in the presence of 10 µM of compound 7, compound 4 and compound 5
(from bottom to top). D: staining parameters at a lectin concentration of 10 µg/ml in the absence of inhibitor (100 %-value) and in the presence of 25 nM/50 nM of compound 6.
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Fig. 4
Fluorescent cell (CHO Lec8 mutant) surface staining by the labeled C-type CRD + stalk construct (for further details, please see legend to Fig. 2) . A: staining parameters with increasing lectin concentrations (from top to bottom) of 2 µg/ml, 10 µg/ml and 20 µg/ml. B: staining parameters at a lectin concentration of 20 µg/ml in the absence of inhibitor (100 %-value) and in the presence of 50 mM and 100 mM GalNAc (from bottom to top). C:
staining parameters at a lectin concentration of 20 µg/ml in the absence of inhibitor (100 %-value) and in the presence of 500 µM of compound 2, 0.5 µM of compound 5 and 1 µM of compound 4 (from bottom to top). D: staining parameters at a lectin concentration of 20
